[1] |
MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong.
Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
|
[2] |
Beijing Chest Hospital, Capital Medical University, Non-tuberculous Mycobacterial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus on off-label use of drugs for non-tuberculous mycobacteria
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 769-787.
|
[3] |
ZHAO Ai-hua, KANG Wan-li, WANG Guo-zhi, GAO Zheng-lun, DU Wei-xin, LU Jin-biao, SHEN Xiao-bing, SU Cheng, XU Miao, ZHENG Su-hua.
Screening for latent tuberculosis infection and identification of BCG vaccination by recombinant Mycobacterium tuberculosis 11 kDa
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 821-825.
|
[4] |
SHENG Jie, ZHU Yang, Dilixiati·Abulizi , TANG Wei, GU Fu-ding, SONG Xing-hua.
Individualized treatment of drug-resistant osteoarticular tuberculosis based on phenotypic and molecular drug susceptibility tests and its short-term effectiveness evaluation
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 838-844.
|
[5] |
CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui.
Possible causes of infection after BCG vaccination
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 869-873.
|
[6] |
WANG Ni, ZHANG Hui, ZHANG Tie-juan, CHEN Bin, LEI Juan, SUN Miao-miao, HUANG Fei.
Analysis of using electronic pillbox to assist the medication management of pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 682-686.
|
[7] |
XIE Li, GAO Jing-tao, MA Li-ping, ZHANG Li-qun, KONG Zhong-shun, WU Xiao-guang, LIU Rong-mei, CHEN Hong-mei, SONG Yan-hua, LI Xue-lian, Huang Mai-ling, LI Qiang, Lv Zi-zheng, LIu Yv-hong, Gao Meng-qiu.
Effect of bedaquiline-containing regimen on QT interval in patients with multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 687-694.
|
[8] |
ZHENG Ya-mei, XIE Tian, WU Zhuo-le, CHEN Yong-xing.
Clinical value of triple-drug adjuvant therapy for tuberculous pleurisy via chest wall ultrasound
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 695-700.
|
[9] |
ZHAO Ben-nan, LIU Da-feng, LIU Ya-ling, YANG Ming, LAN Li-juan, DU Qing.
Clinical analysis of hypothyroidism after anti-tuberculosis treatment in patients with multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 465-471.
|
[10] |
LU Peng,CHENG Jun,LU Xi-wei,LIU Er-yong,ZHOU Lin,LU Wei.
Scientific preventive treatment to accelerate the process of tuberculosis control
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 316-321.
|
[11] |
XIANG Hai-bin,LIANG Qiu-zhen,LI Xin-xia,SONG Xing-hua.
Advances in the application of anti-tuberculosis nanoscale drug delivery system targeting macrophages
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 398-403.
|
[12] |
QIU Lei,ZHANG Shao-yan,GUO Xiao-yan,FU Ji-you,TIAN Li-ming,ZHANG Hui-yong,LU Zhen-hui.
Clinical value of chemotherapy regimen and Qinbudan tablet on the retreatment of retreated smear-positive pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 108-114.
|
[13] |
WANG Xue-di,JIANG Feng,DAI Qian-lan,WANG Jing,WANG Dong-mei..
Comparative analysis on drug-induced liver injury of the combination of traditional Chinese and Western medicine and single Western medicine in tuberculosis treatment (Literature review 2000-2019)
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 126-132.
|
[14] |
XIA Lu,LU Shui-hua,LIU Ping.
Research progress of immune regulatory mechanism of traditional Chinese medicine on tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 168-172.
|
[15] |
ZHANG Sheng-kang, TONG Zhao-wei, TANG Han-mei, YAN Mi, YUAN Dan, TANG Xi-liang, SHEN Sheng-rong.
Must value nutritional treatment of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1272-1275.
|